Cemtrex (NASDAQ:CETX) reported $8.80 million in sales this quarter. This is a 27.99 percent decrease over sales of $12.22 million the same period last year.
Novel Psychedelic Compound For The Treatment Of Fibromyalgia Begins Dosing In Safety Trial
Developmental-stage psychedelics biotech company Silo Pharma Inc. (NASDAQ: SILO) has begu